Bepotastine Besilate Solution/ Drops
Product Images NDC 0378-7055

5 FDA label images from Mylan Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bepotastine Besilate (NDC 0378-7055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bepotastine Besilate Structural Formula (Image 01)

Bepotastine Besilate Structural Formula (Image 01)
Chemical structure of Bepotastine Besilate, an ophthalmic solution active ingredient, showing its molecular arrangement with characteristic aromatic rings and functional groups.*
FDA Label Image

Bepotastine Besilate Ophthalmic Solution 1.5% Carton Label (Image 02)

Bepotastine Besilate Ophthalmic Solution 1.5% Carton Label (Image 02)
Packaging label for Bepotastine Besilate Ophthalmic Solution 1.5%, an eye drop solution by Mylan Pharmaceuticals Inc. The label indicates a 5 mL size, topical ophthalmic use, and includes details on active ingredient concentration, preservatives, storage conditions (15° to 25°C), and manufacturer information. The label also shows the NDC 0378-7055-35.*
FDA Label Image

Instructions For Use Figure A (Image 03)

Instructions For Use Figure A (Image 03)
Illustration of a Bepotastine Besilate ophthalmic solution dropper bottle labeled with parts including the cap, tear off tamper evident ring, and bottle.*
FDA Label Image

Instructions For Use Figure B (Image 04)

Instructions For Use Figure B (Image 04)
An instructional illustration showing hands holding an ophthalmic solution bottle and twisting or removing the cap, labeled as Figure B. This diagram likely illustrates the proper way to open the dropper bottle of Bepotastine Besilate ophthalmic solution.*
FDA Label Image

Instructions For Use Figure C (Image 05)

Instructions For Use Figure C (Image 05)
An instructional illustration showing a hand holding a bottle of ophthalmic solution or drops, demonstrating the twisting motion to remove or secure the cap. This figure likely corresponds to usage instructions for Bepotastine Besilate 15 mg/mL ophthalmic solution by Mylan Pharmaceuticals Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.